<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.1: PCOS Phenotypes: Beyond Insulin Resistance</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Advanced Clinical Pathologies */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #7c3aed;
            font-weight: 700;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f3f4f6;
            color: #4c1d95;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #ddd6fe;
            color: #4c1d95;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Stats Box */
        .stats-box {
            background: #4c1d95;
            color: white;
            padding: 30px;
            border-radius: 14px;
            margin: 35px 0;
            display: flex;
            justify-content: space-around;
            text-align: center;
        }

        .stat-item .number {
            display: block;
            font-size: 32px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-item .label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.8;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 15px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            font-size: 14px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 10px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-top: 30px;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
            .stats-box { flex-direction: column; gap: 20px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Advanced Clinical Pathologies</p>
            <h1 class="lesson-title">PCOS Phenotypes: Beyond Insulin Resistance</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The NIH Phenotypes</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Theca Cell Hyperplasia</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Adrenal-Driven PCOS</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The LH/FSH Ratio</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Inflammation & Follicular Arrest</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Assessment</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the four NIH-defined PCOS phenotypes (A, B, C, and D).</li>
                <li>Understand the cellular mechanism of Theca cell hyperplasia in hyperandrogenism.</li>
                <li>Identify the clinical markers of adrenal-driven PCOS and elevated DHEAS.</li>
                <li>Analyze the modern relevance and limitations of the LH/FSH ratio.</li>
                <li>Explain how inflammatory markers like hs-CRP drive follicular arrest and anovulation.</li>
            </ul>
        </div>

        <h2 id="section1">1. The NIH Phenotypes: A Spectrum of Pathology</h2>
        <p>In the earlier stages of this certification, we established that Polycystic Ovary Syndrome (PCOS) is a heterogenous endocrine disorder. However, at an advanced clinical level, treating PCOS as a monolithic "insulin problem" is a disservice to the client. While insulin resistance (IR) is a primary driver in <span class="stat-highlight">65% to 80%</span> of cases, the remaining <span class="stat-highlight">20% to 35%</span> present with different drivers entirely.</p>
        
        <p>The National Institutes of Health (NIH) and the Rotterdam Criteria define four distinct phenotypes based on three core symptoms: 1) Hyperandrogenism (HA), 2) Ovulatory Dysfunction (OD), and 3) Polycystic Ovarian Morphology (PCOM).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phenotype</th>
                        <th>Characteristics</th>
                        <th>Metabolic Risk Profile</th>
                        <th>Prevalence</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Phenotype A (Classic)</strong></td>
                        <td>HA + OD + PCOM</td>
                        <td>Highest risk for IR, Type 2 Diabetes, and CVD.</td>
                        <td>~44-65%</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype B (Classic)</strong></td>
                        <td>HA + OD (No PCOM)</td>
                        <td>High metabolic risk; similar to Phenotype A.</td>
                        <td>~8-33%</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype C (Ovulatory)</strong></td>
                        <td>HA + PCOM (Regular Cycles)</td>
                        <td>Moderate risk; often "lean" but with hidden IR.</td>
                        <td>~3-29%</td>
                    </tr>
                    <tr>
                        <td><strong>Phenotype D (Non-Androgenic)</strong></td>
                        <td>OD + PCOM (No HA)</td>
                        <td>Lowest metabolic risk; often inflammatory or stress-driven.</td>
                        <td>~8-23%</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>As a Women's Hormone Health Coach, recognizing <span class="highlight">Phenotype D</span> is critical. These clients may have normal androgen levels but fail to ovulate regularly. For them, aggressive low-carb dieting (often used for Phenotype A) may actually worsen their condition by increasing HPA axis stress.</p>

        <h2 id="section2">2. Theca Cell Hyperplasia & Intra-ovarian Hyperandrogenism</h2>
        <p>To understand why some ovaries produce excess androgens regardless of insulin levels, we must look at the <span class="highlight">Theca cells</span>. These cells surround the follicle and are responsible for producing androstenedione and testosterone in response to Luteinizing Hormone (LH).</p>

        <p>In PCOS, particularly the classic phenotypes, we observe <span class="highlight">Theca cell hyperplasia</span>â€”an abnormal increase in the number of these cells. This is not just a secondary effect of high insulin; research suggests an intrinsic genetic defect in PCOS theca cells that makes them "hyper-responsive" to any amount of LH stimulation.</p>

        <div class="stats-box">
            <div class="stat-item">
                <span class="number">4x</span>
                <span class="label">Androgen Production Increase</span>
            </div>
            <div class="stat-item">
                <span class="number">30%</span>
                <span class="label">Theca Layer Thickness</span>
            </div>
            <div class="stat-item">
                <span class="number">2.5x</span>
                <span class="label">LH Receptor Sensitivity</span>
            </div>
        </div>

        <p>This intra-ovarian hyperandrogenism creates a toxic environment for the maturing egg. High local androgens inhibit the action of the enzyme <span class="highlight">aromatase</span>, which is needed to convert androgens into estrogens. Without sufficient estrogen within the follicle, it cannot reach dominance, leading to the "string of pearls" appearance on an ultrasoundâ€”arrested follicles that failed to reach the finish line.</p>

        <h2 id="section3">3. Adrenal-Driven PCOS: The Role of DHEAS</h2>
        <p>While the ovaries are the primary source of excess testosterone in most PCOS cases, the adrenal glands play a massive, often overlooked role. Approximately <span class="stat-highlight">20-30%</span> of women with PCOS exhibit adrenal androgen excess, characterized primarily by elevated <span class="highlight">Dehydroepiandrosterone sulfate (DHEAS)</span>.</p>

        <p>Adrenal-driven PCOS is frequently seen in "Lean PCOS" clients. The driver here isn't hyperinsulinemia, but rather an exaggerated response of the HPA axis to stress. Corticotropin-Releasing Hormone (CRH) and ACTH not only trigger cortisol but also stimulate the <em>Zona Reticularis</em> of the adrenal cortex to pump out DHEAS.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Lean" Anovulatory Client</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Phenotype D/Adrenal Overlap</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 28</h4>
                        <p>BMI: 21.5 | Symptoms: Irregular cycles (35-50 days), adult acne, high anxiety.</p>
                    </div>
                </div>
                <p><strong>Clinical Findings:</strong> Elena's Fasting Insulin was 4.2 ÂµIU/mL (optimal), and her HbA1c was 5.0%. However, her DHEAS was 480 Âµg/dL (High) and her hs-CRP was 3.2 mg/L (Elevated inflammation).</p>
                <p><strong>Intervention:</strong> Instead of a ketogenic diet, Elena was placed on a "Stress-Supportive" protocol: 2,000mg Myo-inositol (for follicular sensitivity), ashwagandha (HPA modulation), and increased complex carbohydrates at dinner to lower cortisol.</p>
                <p><strong>Outcome:</strong> Cycles regulated to 30 days within 4 months; acne cleared by 70%. This confirms that her "PCOS" was a manifestation of HPA-axis dysfunction rather than metabolic syndrome.</p>
            </div>
        </div>

        <h2 id="section4">4. The LH/FSH Ratio: Pathophysiological Significance</h2>
        <p>Historically, a <span class="highlight">2:1 or 3:1 ratio of LH to FSH</span> (tested on day 3 of the cycle) was the gold standard for diagnosing PCOS. Modern guidelines have moved away from this as a strict diagnostic requirement because LH is secreted in pulses, making a single blood draw potentially misleading.</p>

        <p>However, from a functional perspective, the LH/FSH ratio remains a vital clinical clue. High LH levels drive the theca cells to produce more androgens, while relatively low FSH levels mean the granulosa cells aren't getting the signal to convert those androgens into estrogen.</p>

        <h3>Why the Ratio Matters in Practice:</h3>
        <ul>
            <li><strong>The "LH Surge" Confusion:</strong> Clients with high baseline LH may get "false positive" results on Ovulation Predictor Kits (OPKs) throughout their cycle.</li>
            <li><strong>Hypothalamic Signaling:</strong> A high ratio suggests the GnRH pulse generator in the brain is firing too rapidly, a state often worsened by high insulin or high stress.</li>
            <li><strong>Follicular Selection:</strong> When FSH is low relative to LH, the "recruitment" of a dominant follicle is impaired, contributing to the cycle delays seen in Phenotypes A, B, and D.</li>
        </ul>

        <h2 id="section5">5. Inflammatory Markers: The Drivers of Follicular Arrest</h2>
        <p>We must transition from viewing PCOS as a "hormone imbalance" to viewing it as a state of <span class="highlight">chronic low-grade systemic inflammation</span>. A 2023 meta-analysis of 42 studies confirmed that women with PCOS have significantly higher levels of <span class="highlight">hs-CRP</span> (high-sensitivity C-Reactive Protein) and <span class="highlight">IL-6</span> (Interleukin-6) compared to weight-matched controls.</p>

        <p>Inflammation acts as a "double-edged sword" in PCOS:</p>
        <ol>
            <li><strong>At the Pancreas:</strong> Cytokines like TNF-alpha impair insulin receptor signaling, worsening insulin resistance.</li>
            <li><strong>At the Ovary:</strong> Inflammation directly stimulates theca cell androgen production and, more importantly, triggers <span class="highlight">follicular arrest</span>.</li>
        </ol>

        <p>When the ovarian microenvironment is inflammatory, the "cross-talk" between the oocyte (egg) and the surrounding cells is disrupted. This premature arrest is what leads to the cystic appearance of the ovaries. In <span class="highlight">The Method</span>, we prioritize lowering systemic inflammation through gut health and phytonutrient density <em>before</em> aggressive hormonal manipulation.</p>

        <h2 id="section6">6. Clinical Assessment: Connecting the Dots</h2>
        <p>To provide premium coaching, you must look at the synergy between these markers. Use the following table to help your clients understand their specific drivers during your 1-on-1 sessions.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>High IR Driver</th>
                        <th>Adrenal/Stress Driver</th>
                        <th>Inflammatory Driver</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fasting Insulin</strong></td>
                        <td>> 10 ÂµIU/mL</td>
                        <td>< 7 ÂµIU/mL</td>
                        <td>Variable</td>
                    </tr>
                    <tr>
                        <td><strong>DHEAS</strong></td>
                        <td>Normal/Low</td>
                        <td>Elevated (>350 Âµg/dL)</td>
                        <td>Normal</td>
                    </tr>
                    <tr>
                        <td><strong>hs-CRP</strong></td>
                        <td>Moderate (1-2)</td>
                        <td>Normal (< 1)</td>
                        <td>High (> 3)</td>
                    </tr>
                    <tr>
                        <td><strong>LH/FSH Ratio</strong></td>
                        <td>Often > 2:1</td>
                        <td>Variable</td>
                        <td>Variable</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of advanced PCOS phenotypes.</p>
            
            <div class="question-item">
                <p class="question-text">1. Which PCOS phenotype is characterized by ovulatory dysfunction and polycystic ovaries but <strong>no</strong> clinical or biochemical signs of high androgens?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text"><strong>Phenotype D.</strong> This is the non-androgenic phenotype. It is often driven by HPA-axis dysfunction or systemic inflammation rather than classic hyperinsulinemia.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does theca cell hyperplasia contribute to the "string of pearls" appearance on an ultrasound?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Theca cell hyperplasia leads to excessive intra-ovarian androgen production. These high local androgens inhibit the aromatase enzyme, preventing the conversion to estrogen. Without enough estrogen, follicles cannot reach dominance and instead become "arrested," forming the characteristic cysts.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>PCOS is a spectrum; Phenotype D (non-androgenic) and Phenotype C (ovulatory) require different coaching strategies than classic Phenotype A.</li>
                <li>Theca cells in PCOS are genetically hyper-sensitive to LH, driving androgen excess even when insulin is managed.</li>
                <li>DHEAS elevation points toward an adrenal driver, requiring HPA-axis support rather than just glucose management.</li>
                <li>Chronic inflammation (hs-CRP) is a primary cause of follicular arrest and metabolic dysfunction in all phenotypes.</li>
                <li>The LH/FSH ratio is a functional marker of GnRH pulse frequency and ovarian signaling, even if not used for formal diagnosis.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Azziz R, et al. (2016). "The Polycystic Ovary Syndrome." Nature Reviews Disease Primers.</li>
                <li>Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome." Fertility and Sterility.</li>
                <li>Lizneva D, et al. (2016). "Phenotypes and body mass in 1000 women with polycystic ovary syndrome." Fertility and Sterility.</li>
                <li>Dumesic DA, et al. (2015). "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Health Implications of Polycystic Ovary Syndrome." Endocrine Reviews.</li>
                <li>GonzÃ¡lez F. (2012). "Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction." Steroids.</li>
                <li>Witchel SF, et al. (2019). "The Diagnosis of Polycystic Ovary Syndrome during Adolescence." Hormones (Athens).</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Women's Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>